Real-time drug release monitoring from pH-responsive CuS-encapsulated metal-organic frameworks

10Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Real-time monitoring of drug release behaviors over extended periods of time is critical in understanding the dynamics of drug progression for personalized chemotherapeutic treatment. In this work, we report a metal-organic framework (MOF)-based nanotheranostic system encapsulated with photothermal agents (CuS) and therapeutic drug (DOX) to achieve the capabilities of real-time drug release monitoring and combined chemo-photothermal therapy. Meanwhile, folic acid-conjugated polyethylene glycol (FA-PEG) antennas were connected to the MOF through coordination interactions, endowing the MOF with an enhanced active targeting effect toward cancer cells. It is anticipated that such a theranostic agent, simultaneously possessing tumor-targeting, real-time drug monitoring and effective treatment, will potentially enhance the performance in cancer therapy.

Cite

CITATION STYLE

APA

Liu, B., Sun, L., Lu, X., Yang, Y., Peng, H., Sun, Z., … Chu, H. (2022). Real-time drug release monitoring from pH-responsive CuS-encapsulated metal-organic frameworks. RSC Advances, 12(18), 1119–1127. https://doi.org/10.1039/d1ra09320g

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free